Kantar Health is a market research agency that specialises in pharmaceutical research, they regularly speak to physicians, patients and carers and have a wealth of experience in conducting healthcare research. They work on behalf of pharmaceutical companies to speak to and understand how various health issues impact people’s live. On this occasion, Kantar Health would like to talk to patients who have been diagnosed with ALK+ Non-Small Cell Lung Cancer (NSCLC), and are undergoing treatment.
The research will be individual in-depth interviews that will take approximately 1 hour and will be conducted either via a secure video link (like Skype or FaceTime), or in your home if you feel comfortable doing so. As part of the research the company will also be asking participants to complete a diary or task for 10-15 minutes per day, for 5 days prior to the interview.
The aim of this research is to better understand patient journeys, when, where and with whom they interact before and after their diagnosis, and identify support they may have and / or need.
All information that is shared as part of the interview will be kept strictly confidential and there will be no attempt to sell you anything. Your decision to participate, or not, will not influence any current or future treatment decisions.
Kantar Health’s interviews are carried out in accordance with current (European: MRS, EphMRA, ESOMAR, BHBIA) guidelines and Data Protection Laws as well as with local UK specific rules.
As an appreciation of your time participants will receive an amount of £200 in your choice of bank transfer or cheque.
If you are interested in taking part, please contact Megan Grendon from Gillian Kenny Associates on 01242 240 842 or MeganGrendon@gilliankenny.com
Gillian Kenny Associates is the medical market research agency that Kantar Health is using to recruit individuals to see if you are eligible for the study.
